AzTrials
AzTrials

StrabismusNCT05615519

Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus

An observational study of Strabismus and Exotropia, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The current measurement methods of strabismus include the corneal light reflection method, prism alternate covering, etc., which especially rely on the subjective experience of doctors, and there is a large error between different measurers, leading to serious underestimation of strabismus prevalence and insufficient… Read more about this study

Who is it for?
Ages 3 years and olderHealthy volunteers can take part
Conditions the study is for
Strabismus, Exotropia, Esotropia
What is being tested?
A new technology based on 3D reconstruction and deep learning algorithm to achieve an automatic diagnosis of strabismus based on patient-sourced videos of programmatic cover tests.
How many people
300 participants
Where
1 siteChina
Study dates
2 Dec 2022to 1 Apr 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Outpatients from strabismus \& optometry departments or participants from the internet.

Who may be able to join

  • The quality of facial videos should be clinically acceptable.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Haotian Lin, M.D., Ph.D contact

8613802793086

haot.lin@hotmail.com

Ruixin Wang, M.D., Ph.D contact

8615360458084

ruiruiw413@aliyun.com

China1 site, 1 recruiting
  • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

    Guangzhou, Guangdong, 510060

    Haotian Lin, Ph.D, +86-020-87330274, gddlht@aliyun.com

    Haotian Lin, Ph.D

    Recruiting

Other trials in China

About this study

The current measurement methods of strabismus include the corneal light reflection method, prism alternate covering, etc., which especially rely on the subjective experience of doctors, and there is a large error between different measurers, leading to serious underestimation of strabismus prevalence and insufficient care for strabismus patients. Here, the investigators established and validated an artificial intelligence system to achieve an automatic diagnosis of strabismus based on patient-sourced videos of programmatic cover tests. Three-dimensional reconstruction methods are used to digitize the parameters of head and eye positions. This system has been integrated into a smartphone platform to be further validated through hospital-based and population-based clinical trials.

Being tested
A new technology based on 3D reconstruction and deep learning algorithm to achieve an automatic diagnosis of strabismus based on patient-sourced videos of programmatic cover tests.
Keywords
Mobile health, Artificaial intelligence medicine, Pediatric ophthalmology
Medical subject headings
Strabismus, Exotropia, Esotropia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A new technology based on 3D reconstruction and deep learning algorithm to achieve an automatic diagnosis of strabismus based on patient-sourced videos of programmatic cover tests.Diagnostic test

    Digital ruler of strabismus

Study groups in NCT05615519
Study groupRoleWhat they receive
Eligible participants for smartphone-based strabismus measurement and diagnosisFacial videos dataset Facial videos were collected using smartphone and following the programmatic cover tests.
Receives: Diagnostic Test: A new technology based on 3D reconstruction and deep learning algorithm to achieve an automatic diagnosis of strabismus based on patient-sourced videos of programmatic cover tests.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The effectiveness of smartphone-based diagnosis

    The accurate and the area under curve of the smartphone-based diagnosis.

    Measured: Baseline

  2. The consistency between manual and smartphone measurement

    Agreement between the manual and automated tests was represented in Bland-Altman plots and concordance correlation coefficients.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2022
  2. Study start2 Dec 2022 (estimated)
  3. Primary completion1 Mar 2023 (estimated)
  4. Study completion1 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05615519
Sponsor's protocol ID
DRStrabismus2022
Status last verified
Dec 2022
First submitted
7 Nov 2022
Last updated
5 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wang R, Lyu J, Yang Y, Bi S, Yu H, Deng H, Han M, Ma W, Wan M, Peng S, Yu X, Xu F, Lin H. A Smartphone-Based Digital Ruler to Automatically Measure Strabismus in Ophthalmologist-Level: A Prospective, Multicenter Cohort Study. NEJM AI. 2025 Nov;2(11):AIoa2401205. doi: 10.1056/AIoa2401205. Epub 2025 Oct 23.

    PubMed 42932718

Questions about this trial

What is this clinical trial studying?

An observational study of Strabismus and Exotropia, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Haotian Lin, M.D., Ph.D (8613802793086, haot.lin@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The effectiveness of smartphone-based diagnosis (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05615519, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in